Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Abbvie Inc shares valued at $12,359,504 were sold by Stewart Jeffrey Ryan on Mar 31 ’25. At $210.08 per share, Stewart Jeffrey Ryan sold 58,832 shares. The insider’s holdings dropped to 53,234 shares worth approximately $10.19 million following the completion of this transaction.
Also, Stewart Jeffrey Ryan purchased 58,832 shares, netting a total of over 12,359,897 in proceeds.
Before that, Reents Scott T had sold 17,644 shares from its account. In a trade valued at $3,746,527, the EVP, CHIEF FINANCIAL OFFICER traded Abbvie Inc shares for $212.34 each. Upon closing the transaction, the insider’s holdings decreased to 17,644 shares, worth approximately $2.22 million.
As published in a research note from Citigroup on May 14, 2025, Abbvie Inc [ABBV] has been rated down from a Buy to a Neutral and the price target has been revised to $205. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in late April. Earlier on December 05, 2024, Daiwa Securities downgraded its rating. Their new recommendation was “a Neutral” for ABBV stock which previously was a “an Outperform”.
Analyzing ABBV Stock Performance
During the last five days, there has been a surge of approximately 2.22%. Over the course of the year, Abbvie Inc shares have jumped approximately 7.77%. Shares of the company reached a 52-week high of $218.66 on 03/10/25 and a 52-week low of $164.39 on 04/09/25.
Support And Resistance Levels for Abbvie Inc (ABBV)
According to the 24-hour chart, there is a support level at 189.47, which, if violated, would cause prices to drop to 187.43. In the upper region, resistance lies at 193.13. The next price resistance is at 194.75. RSI (Relative Strength Index) is 58.52 on the 14-day chart, showing neutral technical sentiment.
